Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002090655-25-000002·BriaCell Therapeutics Corp.
Schedule 13G ownership disclosure
BriaCell Therapeutics Corp.
13G · CUSIP: 10778Y104
Event date: 2025-08-25
- Filing-level shares
- 13,338.61
- Percent of class
- 100.0%
- Plambeck Jeremy Myung Jae
Shares: 13,338.61 · Class: 100.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002090655-25-000002
- Form type
- SCHEDULE 13G
- Filer
- BriaCell Therapeutics Corp.
- CIK
- CIK 1610820
- Filed
- Oct 10, 2025
- Reporting period
- Aug 25, 2025
- Description
- Schedule 13G beneficial ownership